Dr. Scott C. Morgan
Claim this profileOttawa Hospital Research Institute
Studies Prostate Cancer
Studies Renal Cell Carcinoma
5 reported clinical trials
22 drugs studied
Affiliated Hospitals
Clinical Trials Scott C. Morgan is currently running
Local Ablative Therapy
for Prostate Cancer
The purpose of this study is to compare the effects of ablative therapy (radiation or surgery) to all sites of disease combined with standard treatments on prostate cancer, compared to the standard or usual treatments used to treat this disease.
Recruiting1 award N/A
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
More about Scott C. Morgan
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Scott C. Morgan has experience with
- Ipilimumab/Nivolumab
- SBRT
- Darolutamide
- External Beam Radiotherapy
- Luteinizing Hormone-Releasing Hormone Analog
- Placebo Oral Tablet
Breakdown of trials Scott C. Morgan has run
Prostate Cancer
Renal Cell Carcinoma
Kidney Tumors
Kidney Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott C. Morgan specialize in?
Scott C. Morgan focuses on Prostate Cancer and Renal Cell Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Scott C. Morgan currently recruiting for clinical trials?
Yes, Scott C. Morgan is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Scott C. Morgan has studied deeply?
Yes, Scott C. Morgan has studied treatments such as Ipilimumab/Nivolumab, SBRT, Darolutamide.
What is the best way to schedule an appointment with Scott C. Morgan?
Apply for one of the trials that Scott C. Morgan is conducting.
What is the office address of Scott C. Morgan?
The office of Scott C. Morgan is located at: Ottawa Hospital Research Institute, Toronto, Ontario K1H 8L6 Canada. This is the address for their practice at the Ottawa Hospital Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.